Medpace Holdings, Inc. (MEDP)
MEDP Stock Price Chart
Explore Medpace Holdings, Inc. interactive price chart. Choose custom timeframes to analyze MEDP price movements and trends.
MEDP Company Profile
Discover essential business fundamentals and corporate details for Medpace Holdings, Inc. (MEDP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
11 Aug 2016
Employees
5.90k
Website
https://www.medpace.comCEO
August James Troendle
Description
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
MEDP Financial Timeline
Browse a chronological timeline of Medpace Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Jul 2026
EPS estimate is $3.98, while revenue estimate is $689.53m.
Earnings released on 22 Apr 2026
EPS came in at $4.28 surpassing the estimated $3.92 by +9.18%, while revenue for the quarter reached $706.60m , beating expectations by +1.29%.
Earnings released on 9 Feb 2026
EPS came in at $4.67 surpassing the estimated $4.19 by +11.46%, while revenue for the quarter reached $708.45m , beating expectations by +2.78%.
Earnings released on 22 Oct 2025
EPS came in at $3.86 surpassing the estimated $3.53 by +9.35%, while revenue for the quarter reached $659.90m , beating expectations by +2.95%.
Earnings released on 21 Jul 2025
EPS came in at $3.10 surpassing the estimated $2.98 by +4.03%, while revenue for the quarter reached $603.31m , beating expectations by +11.98%.
Earnings released on 21 Apr 2025
EPS came in at $3.67 surpassing the estimated $3.06 by +19.93%, while revenue for the quarter reached $558.57m , beating expectations by +6.12%.
Earnings released on 10 Feb 2025
EPS came in at $3.67 surpassing the estimated $2.96 by +23.99%, while revenue for the quarter reached $536.59m , missing expectations by -0.58%.
Earnings released on 21 Oct 2024
EPS came in at $3.01 surpassing the estimated $2.78 by +8.27%, while revenue for the quarter reached $533.32m , missing expectations by -0.29%.
Earnings released on 22 Jul 2024
EPS came in at $2.75 surpassing the estimated $2.54 by +8.27%, while revenue for the quarter reached $528.10m , missing expectations by -0.06%.
Earnings released on 22 Apr 2024
EPS came in at $3.20 surpassing the estimated $2.47 by +29.55%, while revenue for the quarter reached $511.04m , missing expectations by -0.26%.
Earnings released on 12 Feb 2024
EPS came in at $2.46 surpassing the estimated $2.22 by +10.81%, while revenue for the quarter reached $498.40m , missing expectations by -2.67%.
Earnings released on 23 Oct 2023
EPS came in at $2.22 surpassing the estimated $2.05 by +8.29%, while revenue for the quarter reached $492.50m , beating expectations by +3.52%.
Earnings released on 24 Jul 2023
EPS came in at $1.93 surpassing the estimated $1.91 by +1.05%, while revenue for the quarter reached $460.87m , beating expectations by +2.81%.
Earnings released on 24 Apr 2023
EPS came in at $2.27 surpassing the estimated $1.80 by +26.11%, while revenue for the quarter reached $434.07m , beating expectations by +3.41%.
Earnings released on 13 Feb 2023
EPS came in at $2.12 surpassing the estimated $1.79 by +18.44%, while revenue for the quarter reached $394.10m , beating expectations by +2.09%.
Earnings released on 24 Oct 2022
EPS came in at $2.05 surpassing the estimated $1.47 by +39.46%, while revenue for the quarter reached $383.74m , beating expectations by +7.44%.
Earnings released on 25 Jul 2022
EPS came in at $1.46 surpassing the estimated $1.31 by +11.45%, while revenue for the quarter reached $351.21m , beating expectations by +2.09%.
Earnings released on 25 Apr 2022
EPS came in at $1.69 surpassing the estimated $1.26 by +34.13%, while revenue for the quarter reached $330.95m , beating expectations by +1.18%.
Earnings released on 14 Feb 2022
EPS came in at $1.32 surpassing the estimated $1.25 by +5.60%, while revenue for the quarter reached $308.55m , missing expectations by -0.16%.
Earnings released on 25 Oct 2021
EPS came in at $1.29 surpassing the estimated $1.07 by +20.56%, while revenue for the quarter reached $295.57m , beating expectations by +1.17%.
Earnings released on 26 Jul 2021
EPS came in at $1.06 surpassing the estimated $0.99 by +7.07%, while revenue for the quarter reached $278.29m , missing expectations by -4.74%.
MEDP Stock Performance
Access detailed MEDP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
